U.S. markets closed
  • S&P 500

    3,269.96
    -40.15 (-1.21%)
     
  • Dow 30

    26,501.60
    -157.51 (-0.59%)
     
  • Nasdaq

    10,911.59
    -274.00 (-2.45%)
     
  • Russell 2000

    1,538.48
    -23.10 (-1.48%)
     
  • Crude Oil

    35.72
    -0.45 (-1.24%)
     
  • Gold

    1,878.80
    +10.80 (+0.58%)
     
  • Silver

    23.72
    +0.35 (+1.52%)
     
  • EUR/USD

    1.1641
    -0.0037 (-0.31%)
     
  • 10-Yr Bond

    0.8600
    +0.0250 (+2.99%)
     
  • GBP/USD

    1.2953
    +0.0030 (+0.23%)
     
  • USD/JPY

    104.6350
    +0.0250 (+0.02%)
     
  • BTC-USD

    13,813.88
    +95.08 (+0.69%)
     
  • CMC Crypto 200

    265.42
    +1.78 (+0.68%)
     
  • FTSE 100

    5,577.27
    -4.48 (-0.08%)
     
  • Nikkei 225

    22,977.13
    -354.81 (-1.52%)
     

SHAREHOLDER ALERT: Halper Sadeh LLP Is Investigating the Following Companies; Shareholders are Encouraged to Contact the Firm – PTI, BYFC, RST, AIMT

·2 mins read

NEW YORK, NY / ACCESSWIRE / September 22, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:

Proteostasis Therapeutics, Inc. (NASDAQ:PTI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Yumanity Therapeutics. Under the terms of the merger agreement, Proteostasis will acquire all outstanding shares of Yumanity in exchange for newly-issued shares of Proteostasis common stock, with existing Proteostasis shareholders expected to own approximately 32.5% of the combined company. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/proteostasis-therapeutics-inc-pti-yumanity-stock-merger/.

Broadway Financial Corporation (NASDAQ:BYFC) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with CFBanc Corporation. Under the terms of the merger agreement, CFBanc common shareholders will receive 13.626 shares of Broadway Financial common stock for each share of CFBanc common stock they own. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/broadway-financial-corporation-byfc-stock-merger-cfbanc/.

Rosetta Stone Inc. (NYSE:RST) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Cambium Learning Group for $30 per share. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/rosetta-stone-inc-rst-stock-merger-cambium/.

Aimmune Therapeutics, Inc. (NASDAQ:AIMT) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Sociétés des Produits Nestlé, S.A. for $34.50 per share. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/aimmune-therapeutics-inc-aimt-stock-merger-nestle/.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP



View source version on accesswire.com:
https://www.accesswire.com/607356/SHAREHOLDER-ALERT-Halper-Sadeh-LLP-Is-Investigating-the-Following-Companies-Shareholders-are-Encouraged-to-Contact-the-Firm-PTI-BYFC-RST-AIMT